Apoptomirs: Small molecules have gained the license to kill

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages

  Vecchione, Andrea ^a,b   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7 PROTEIN; MICRORNA; MICRORNA 106B 25; MICRORNA 15A; MICRORNA 16 1; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 29; MICRORNA 34; MICRORNA 98; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXICITY; GENE CLUSTER; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; DRUG RESISTANCE, NEOPLASM; EVOLUTION, MOLECULAR; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; RNA, NEOPLASM; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77449146203     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0163     Document Type: Review

References (126)

1. Akao Y, Nakagawa Y & Naoe T 2006 Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biological & Pharmaceutical Bulletin 29 903-906.
2. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA et al. 2008 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Research 68 6162-6170.
3. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S & Allgayer H 2008 MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27 2128-2136.
4. Ashkenazi A 2002 Targeting death and decoy receptors of the tumor-necrosis factor superfamily. Nature Reviews. Cancer 2 420-430.
5. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH & Wallach D 1995 A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. Journal of Biological Chemistry 270 7795-7798.
6. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB et al. 2007 p53-Mediated activation of miRNA34 candidate tumor-suppressor genes. Current Biology 17 1298-1307.
7. Brennecke J, Hipfner DR, Stark A, Russell RB & Cohen SM 2003 Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113 25-36.
8. Brooks CL & Gu W 2009 How does SIRT1 affect metabolism, senescence and cancer? Nature Reviews. Cancer 9 123-128.
9. Bush JA & Li G 2003 The role of Bcl-2 family members in the progression of cutaneous melanoma. Clinical & Experimental Metastasis 20 531-539.
10. Bushati N & Cohen SM 2007 microRNA functions. Annual Review of Cell and Development Biology 23 175-205.
11. Cai X, Hagedorn C & Cullen BR 2004 Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 1957-1966.
12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M et al. 2004 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. PNAS 101 2999-3004.
13. Calin GA, Ferracin M, Cimmino A, Di Leva G, Simizu M, Wojcic SE, Iorio MV, Visone R, Sever NI, FabbriMet al. 2005 A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New England Journal of Medicine 353 1793-1801.
14. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI et al. 2008 MiR-15a and miR-16-1 cluster functions in human leukemia. PNAS 105 5166-5171.
15. Chan JA, Krichevsky AM & Kosik KS 2005 MicroRNA-21 is an antiapototic factor in human glioblastoma cells. Cancer Research 65 6029-6033.
16. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ et al. 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Molecular Cell 26 745-752.
17. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM & Huang DC 2005 Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Molecular Cell 17 393-403.
18. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL & Wang DZ 2006 The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics 38 228-233.
19. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K & Shiekhattar R 2005 TRBP recruits the Dicer complex to Ago 2 for microRNA processing and gene silencing. Nature 436 740-744.
20. Chinnaiyan AM, O'Rourke K, Tewari M & Dixit VM 1995 FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81 505-512.
21. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM & Farace MG 2005 Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and Biophysical Research Communications 334 1351-1358.
22. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2. PNAS 102 13944-13949.
23. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S & Colburn NH 1999 Differentially expressed protein Pdcd4 inhibits tumor promoter induced neoplastic transformation. PNAS 96 14037-14042.
24. Cohen SM, Brennecke J & Stark A 2006 Denoising feedback loops by thresholding - a new role for microRNAs. Genes and Development 20 2769-2772.
25. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W & Nikitin AY 2007 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research 67 8433-8438.
26. Cory S & Adams JM 2002 The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews. Cancer 2 647-656.
27. Coultas L & Strasser A 2003 The role of the Bcl-2 protein family in cancer. Seminars in Cancer Biology 13 115-123.
28. Debatin KM & Krammer PH 2004 Death receptors in chemotherapy and cancer. Oncogene 23 2950-2966.
29. Degterev A, Boyce M & Yuan J 2003 A decade of caspases. Oncogene 22 8543-8567.
30. Deveraux QL & Reed JC 1999 IAP family proteins - suppressors of apoptosis. Genes and Development 13 239-252.
31. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT et al. 2006 Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics 38 1060-1065.
32. Egle A, Harris AW, Bouillet P & Cory S 2004 Bim is a suppressor of Myc-induced mouse B cell leukemia. PNAS 101 6164-6169.
33. Esquela-Kerscher A & Slack FJ 2006 Oncomirs - microRNAs with a role in cancer. Nature Reviews. Cancer 6 259-269.
34. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S et al. 2005 MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. PNAS 102 18081-18086.
35. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A & Lund AH 2008 Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. Journal of Biological Chemistry 283 1026-1033.
36. Fulda S & Debatin KM 2006 Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25 4798-4811.
37. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA & Farace MG 2007 miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. Journal of Biological Chemistry 282 23716-23724.
38. Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM & Condorelli G 2008 MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27 3845-3855.
39. Gautam A, Li ZR & Bepler G 2003 RRM1-induced metastasis suppression through PTEN-regulated pathways. Oncogene 22 2135-2142.
40. Hammond SM, Bernstein E, Beach D & Hannon GJ 2000 An RNA-directed nuclease mediates post-trascriptional gene silencing in Drosophila cells. Nature 404 293-296.
41. Han J, Lee Y, Yeom KH, Kim YK, Jin H & Kim VN 2004 The Drosha-DGCR8 complex in primary microRNA processing. Genes and Development 18 3016-3027.
42. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zebder L, Magnus J, Ridzon D et al. 2007 A microRNA component of the p53 tumour suppressor network. Nature 447 1130-1134.
43. Henry-Mowatt J, Dive C, Martinou JC & James D 2004 Role of mitochondrial membrane permeabilization in apoptosis and cancer. Oncogene 23 2850-2860.
44. Hermeking H 2009 The miR-34 family in cancer and apoptosis. Cell Death and Differentiation online advance publication.
45. Hipfner DR, Weigmann K & Cohen SM 2002 The bantam gene regulates Drosophila growth. Genetics 161 1527-1537.
46. Houbaviy HB, Murray MF & Sharp PA 2003 Embryonic stem cell-specific microRNAs. Developmental Cell 5 351-358.
47. Hwang HW, Wentzel EA & Mendell JT 2007 A hexanucleotide element directs microRNA nuclear import. Science 315 97-100.
48. Igney FH & Krammer PH 2002 Death and anti-death: tumour resistance to apoptosis. Nature Reviews. Cancer 2 277-288.
49. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M et al. 2005 MicroRNA gene expression deregulation in human breast cancer. Cancer Research 65 7065-7070.
50. Jansen AP, Camalier CE & Colburn NH 2005 Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Research 65 6034-6041.
51. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H & Han J 2005 Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120 623-634.
52. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D & Slack FJ 2005 RAS is regulated by the let-7 microRNA family. Cell 120 635-647.
53. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J et al. 2007 The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Research 67 7713-7722.
54. Johnstone RW, Frew AJ & Smyth MJ 2008 The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nature Reviews. Cancer 8 782-798.
55. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV et al. 2009 The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136 1689-1700.
56. Karst AM & Li G 2007 BH3-only proteins in tumorigenesis and malignant melanoma. Cellular and Molecular Life Sciences 64 318-330.
57. Keniry M & Parsons R 2008 The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 41 5477-5485.
58. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ & Plasterk RH 2001 Dicer functions in RNA interference and in synthesis of small RNA involved in the developmental in C. elegans. Genes and Development 15 2654-2659.
59. Kim VN 2005 MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews. Molecular Cell Biology 6 376-385.
60. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH & Peter ME 1995 Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO Journal 14 5579-5588.
61. Kloosterman WP & Plasterk RH 2006 The diverse functions of microRNAs in animal development and disease. Developmental Cell 11 441-450.
62. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, Jensen K, Cobb BS, Merkenschlager M et al. 2008 Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132 860-874.
63. Krichevsky AM & Gabriely G 2009 miR-21: a small multi-faceted RNA. Journal of Cellular and Molecular Medicine 13 39-53.
64. Laitinen S, Martikainen PM, Tolonen T, Isola J, Tammela TL & Visakorpi T 2008 EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients. International Journal of Cancer 122 595-602.
65. Lankat-Buttgereit B & Göke R 2009 The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biology of the Cell 101 309-317.
66. Lavrik IN, Golks A & Krammer PH 2005 Caspases: pharmacological manipulation of cell death. Journal of Clinical Investigation 115 2665-2672.
67. Lee YS & Dutta A 2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes and Development 21 1025-1030.
68. Lee Y, Jeon K, Lee JT, Kim S & Kim VN 2002 MicroRNA maturation: stepwise processing and subcellular localization. EMBO Journal 21 4663-4670.
69. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S & Kim VN 2003 The nuclear RNAse III Drosha initiates microRNA processing. Nature 425 415-419.
70. Lee YS, Kim HK, Chung S, Kim KS & Dutta A 2005 Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the downregulation of putative targets during differentiation. Journal of Biological Chemistry 280 16635-16641.
71. Lewis BP, Burge CB & Bartel DP 2005 Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 15-20.
72. Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF & Cheung AN 2005 Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis. Histopathology 46 307-313.
73. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG & Tan TM 2009 Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Science 100 1234-1242.
74. Longo VD & Kennedy BK 2006 Sirtuins in aging and age-related disease. Cell 126 257-268.
75. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA et al. 2005 MicroRNA expression profiles classify human cancers. Nature 435 834-838.
76. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH & Li Y 2008 MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 31 4373-4379.
77. McKenzie S, Sakamoto S & Kyprianou N 2008 Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 27 7171-7179.
78. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y & Patel T 2007a The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. Journal of Biological Chemistry 282 8256-8264.
79. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST & Patel T 2007b MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 647-658.
80. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S & Majumder S 2008 MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. Journal of Biological Chemistry 283 29897-29903.
81. Mott JL, Kobayashi S, Bronk SF & Gores GJ 2007 mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26 6133-6140.
82. Newman MA, Thomson JM & Hammond SM 2008 Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14 1539-1549.
83. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y & Seto M 2004 Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Research 64 3087-3095.
84. Park MJ, Kim MS, Park IC, Kang HS, Yoo H, Park SH, Rhee CH, Hong SI & Lee SH 2002 PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Research 62 6318-6322.
85. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P et al. 2000 Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 86-89.
86. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y & Hattori T 2003 Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase-and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. Journal of Pathology 201 439-450.
87. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M et al. 2008 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13 272-286.
88. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z & Oren M 2007 Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Molecular Cell 26 731-743.
89. Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, Mayer EG, Yu H, Pardoll DM, Ashkenazi A & Bedi A 2004 Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Cancer Research 64 9105-9114.
90. Reed JC 1998 Bcl-2 family proteins. Oncogene 17 3225-3236.
91. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR & Ruvkun G 2000 The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 901-906.
92. Rieger J, Naumann U, Glaser T, Ashkenazi A & Weller M 1998 APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Letters 427 124-128.
93. Rowinsky EK 2005 Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. Journal of Clinical Oncology 23 9394-9407.
94. Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R & Wulczyn FG 2008 A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stemcell commitment. Nature Cell Biology 10 987-993.
95. Sanchez-Beato M, Sanchez-Aguilera A & Piris MA 2003 Cell cycle deregulation in B-cell lymphomas. Blood 101 1220-1235.
96. Schaefer U, Voloshanenko O, Willen D & Walczak H 2007 TRAIL: a multifunctional cytokine. Frontiers in Bioscience 12 3813-3824.
97. Schimmer AD 2004 Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Research 64 7183-7190.
98. Si ML, Zhu S, Wu H, Lu Z, Wu F & Mo YY 2007 miR-21-mediated tumor growth. Oncogene 26 2799-2803.
99. Silverman GA, Bird PI, Carrell RW, Coughlin PB, Gettins PG, Irving JI, Lomas DA, Luke CJ, Moyer RW, Pemberton J et al. 2001 The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. Journal of Biological Chemistry 276 33293-33296.
100. Singh SK, Kagalwala MN, Parker-Thornburg J, Adams H & Majumder S 2008 REST maintains self renewal and pluripotency of embryonic stem cells. Nature 453 223-227.
101. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z & Alnemri ES 2000 Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. Journal of Biological Chemistry 275 36152-36157.
102. Tahmatzopoulos A, Sheng S & Kyprianou N 2005 Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene 24 5375-5383.
103. Takada H, Imoto I, Tsuda H, Sonoda I, Ichikura T, Mochizuki H, Okanoue T & Inazawa J 2005 Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Science 96 100-110.
104. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z & Huang G 2009 MicroRNA-1 regulates cardimomycyte apoptosis by targeting Bcl-2. International Heart Journal 50 377-387.
105. Taniai M, Grambihler A, Higuchi H,Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH & Gores GJ 2004 Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Research 64 3517-3524.
106. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G & Hermeking H 2007 Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6 1586-1593.
107. Tsang WP & Kwok TT 2008 Let-7a microRNA suppresse therapeuthics-induced cancer cell death by targeting caspase-3. Apoptosis 13 1215-1222.
108. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC & Croce CM 1984 Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224 1403-1406.
109. Tsujimoto Y, Cossman J, Jaffe E & Croce CM 1985 Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 1440-1443.
110. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR et al. 2008 Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132 875-886.
111. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM et al. 2007 MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocrine-Related Cancer 14 791-798.
112. Viswanathan SR, Daley GQ & Gregory RI 2008 Selective blockade of microRNA processing by Lin28. Science 320 97-100.
113. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M et al. 2006 A microRNA expression signature of human solid tumors defines cancer gene targets. PNAS 103 2257-2261.
114. Wang S & El-Deiry WS 2003 TRAIL apoptosis induction by TNF; family death receptors. Oncogene 22 8628-8633.
115. Wang J, Chun HJ, Wong W, Spencer DM & Lenardo MJ 2001 Caspase-10 is an initiator caspase in death receptor signaling. PNAS 98 13884-13888.
116. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SG, Albertson D & Meijer GA 2004 Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cellular Oncology 26 307-317.
117. Welch C, Chen Y & Stallings RL 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26 5017-5022.
118. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL & Rajewsky K 2008 Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunology 9 405-414.
119. Xu P, Vernooy SY & Hay BA 2003 The Drosophila microRNA mir-14 suppresses cell death and is required for normal fat metabolism. Current Biology 13 790-795.
120. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z & Yang B 2007 The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. Journal of Cell Science 120 3045-3052.
121. Yamakuchi M, Ferlito M & Lowenstein CJ 2008 miR-34a repression of SIRT1 regulates apoptosis. PNAS 105 13421-13426.
122. Yanaihara N, Caplen N, Bowman E, Seike M, Kumanoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T et al. 2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 189-198.
123. Yi R, Qin Y, Macara IG & Cullen BR 2003 Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes and Development 17 853-858.
124. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917-1920.
125. Zhao Y, Samal E & Srivastava D 2005 Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 214-220.
126. Zhu S, Wu H, Wu F, Nie D, Sheng S & Mo YY 2008 MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research 18 350-359